Renovaro Biosciences Ownership 2024 | Who Owns Renovaro Biosciences Now?
Institutional Ownership
11.01%
Institutional Holders
43.00
Renovaro Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,200 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,507 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -39,324 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -293,631 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -17,263 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -34,261 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -61,484 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -5,068 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -32,652 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -19,994 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -107,897 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,765 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,858 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -43,923 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,779 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -42,068 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
Renovaro Biosciences's largest institutional shareholder is JEFFERIES FINANCIAL GROUP INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,200 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,507 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -39,324 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -293,631 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -17,263 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -34,261 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -61,484 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -5,068 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -32,652 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -19,994 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -107,897 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,765 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,858 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -43,923 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,779 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -42,068 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
The largest Renovaro Biosciences shareholder by % of total assets is JEFFERIES FINANCIAL GROUP INC.. The company owns 0.00 shares of Renovaro Biosciences (ENOB), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,858 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,507 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -5,068 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,765 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,200 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -17,263 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -19,994 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -32,652 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -34,261 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -39,324 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -42,068 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -43,923 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,779 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -61,484 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -107,897 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -293,631 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Renovaro Biosciences's largest institutional buyer is POINT72 ASIA (SINGAPORE) PTE. LTD.. The company purchased -1.86K stocks of ENOB, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -293,631 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -107,897 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -61,484 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,779 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -43,923 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -42,068 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -39,324 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -34,261 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -32,652 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -19,994 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -17,263 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,200 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,765 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -5,068 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,507 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,858 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Renovaro Biosciences's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -0.29M shares of ENOB, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -293,631 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -107,897 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -61,484 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -58,779 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -43,923 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -42,068 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -39,324 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -34,261 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -32,652 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -32,200 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -21,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -19,994 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -17,263 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,200 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,765 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -5,068 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,507 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -1,858 | -100.00% | - | Jun 30, 2024 |
Renovaro Biosciences's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -0.29M shares, valued at -, as of undefined.
Renovaro Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 12,010 | - | - | Mar 28, 2024 |
| Vericimetry Funds | 0.03% | 2,810 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,041 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,770,293 | 3,013,475 | 398.18% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 3,652 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 30,528 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,857 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 22,776 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 16,911 | 1,098 | 6.94% | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 64,442 | 47,983 | 291.53% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 7,869 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 363,568 | 79,986 | 28.21% | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 4,100 | - | - | Mar 28, 2024 |
| Amplify ETF Trust | 0.00% | 36,972 | 36,972 | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 3,473 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 35,933 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 43,414 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 195,836 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,482 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 1,009 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,151 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 114 | - | - | Apr 30, 2021 |
| ALLSPRING MASTER TRUST | 0.00% | 12,650 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 26,211 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 35,276 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,400 | - | - | Mar 31, 2024 |
| Segall Bryant & Hamill Trust | 0.00% | 1,504 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 9,282 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 8,848 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 181 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 118,040 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 147,320 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 36,758 | 14,823 | 67.58% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,621 | 1,996 | 76.04% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 756 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 66,381 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 7,273 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 90 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 250 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,796 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,976 | 776 | 24.25% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,000 | -100 | -9.09% | Mar 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,204 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 12 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 2,337 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,264 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 114 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 4,362 | -426 | -8.90% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 57,998 | -440 | -0.75% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,957 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 6,571 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,568 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 691 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,600 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,462 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 872 | 872 | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,873 | - | - | Feb 29, 2024 |
| Meeder Funds | 0.00% | 1 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 3,300 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 782 | - | - | Mar 28, 2024 |
Renovaro Biosciences's largest mutual fund holder by % of total assets is "BlackRock Advantage SMID Cap Fund, Inc.", owning 12.01K shares, compromising 0.06% of its total assets.
Renovaro Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 43 | 22.86% |
| 31 Dec, 23 | 35 | 52.17% |
| 30 Sep, 23 | 23 | -25.81% |
| 30 Jun, 23 | 31 | -22.50% |
| 31 Mar, 23 | 40 | -6.98% |
| 31 Dec, 22 | 43 | 10.26% |
| 30 Sep, 22 | 39 | -23.53% |
| 30 Jun, 22 | 51 | 18.60% |
| 31 Mar, 22 | 43 | -2.27% |
| 31 Dec, 21 | 44 | 37.50% |
| 30 Sep, 21 | 32 | - |
| 30 Jun, 21 | 32 | -21.95% |
| 31 Mar, 21 | 41 | 2.50% |
| 31 Dec, 20 | 40 | 5.26% |
| 30 Sep, 20 | 38 | 15.15% |
| 30 Jun, 20 | 33 | 3.13% |
| 31 Mar, 20 | 32 | -3.03% |
| 31 Dec, 19 | 33 | 13.79% |
| 30 Sep, 19 | 29 | - |
| 30 Jun, 19 | 29 | 61.11% |
| 31 Mar, 19 | 18 | 800.00% |
| 31 Dec, 18 | 2 | - |
As of 31 Mar 24, 43 institutions are holding Renovaro Biosciences's shares, representing an increase of 22.86% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 7,250,533 | 183.48% |
| 31 Dec, 23 | 2,557,673 | 71.86% |
| 30 Sep, 23 | 1,488,192 | -19.54% |
| 30 Jun, 23 | 1,849,529 | -44.03% |
| 31 Mar, 23 | 3,304,548 | -9.02% |
| 31 Dec, 22 | 3,632,181 | -4.15% |
| 30 Sep, 22 | 3,789,405 | -4.25% |
| 30 Jun, 22 | 3,957,462 | 51.93% |
| 31 Mar, 22 | 2,604,864 | 5.41% |
| 31 Dec, 21 | 2,471,225 | 62.67% |
| 30 Sep, 21 | 1,519,126 | -43.08% |
| 30 Jun, 21 | 2,669,110 | -1.63% |
| 31 Mar, 21 | 2,713,431 | 10.91% |
| 31 Dec, 20 | 2,446,617 | 2.71% |
| 30 Sep, 20 | 2,381,996 | -3.57% |
| 30 Jun, 20 | 2,470,086 | 8.00% |
| 31 Mar, 20 | 2,287,203 | 6.51% |
| 31 Dec, 19 | 2,147,409 | 83.73% |
| 30 Sep, 19 | 1,168,797 | -1.79% |
| 30 Jun, 19 | 1,190,079 | 32.79% |
| 31 Mar, 19 | 896,241 | 30374.02% |
| 31 Dec, 18 | 2,941 | - |
Renovaro Biosciences (ENOB) has 7.25M shares outstanding as of 31 Mar 24, up 183.48% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 11.01% | 72.99% |
| 31 Dec, 23 | 3.88% | 76.05% |
| 30 Sep, 23 | 2.26% | 20.91% |
| 30 Jun, 23 | 3.29% | 9.43% |
| 31 Mar, 23 | 5.90% | 13.79% |
| 31 Dec, 22 | 6.54% | 13.83% |
| 30 Sep, 22 | 6.88% | 12.12% |
| 30 Jun, 22 | 7.53% | 30.77% |
| 31 Mar, 22 | 4.95% | 22.18% |
| 31 Dec, 21 | 4.72% | 55.81% |
| 30 Sep, 21 | 2.91% | 9.08% |
| 30 Jun, 21 | 5.66% | 16.82% |
| 31 Mar, 21 | 5.80% | 21.09% |
| 31 Dec, 20 | 5.24% | 20.07% |
| 30 Sep, 20 | 5.11% | 17.98% |
| 30 Jun, 20 | 5.33% | 21.82% |
| 31 Mar, 20 | 4.94% | 22.95% |
| 31 Dec, 19 | 4.64% | 72.63% |
| 30 Sep, 19 | 2.53% | 25.17% |
| 30 Jun, 19 | 3.17% | 54.22% |
| 31 Mar, 19 | 2.42% | 3671113.58% |
| 31 Dec, 18 | 0.01% | - |
As of 31 Mar 24, Renovaro Biosciences is held by 11.01% institutional shareholders, representing a 72.99% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 29 | - |
| 31 Dec, 23 | 29 | 163.64% |
| 30 Sep, 23 | 11 | - |
| 30 Jun, 23 | 11 | -47.62% |
| 31 Mar, 23 | 21 | 16.67% |
| 31 Dec, 22 | 18 | -5.26% |
| 30 Sep, 22 | 19 | -51.28% |
| 30 Jun, 22 | 39 | 62.50% |
| 31 Mar, 22 | 24 | -20.00% |
| 31 Dec, 21 | 30 | 76.47% |
| 30 Sep, 21 | 17 | 54.55% |
| 30 Jun, 21 | 11 | -50.00% |
| 31 Mar, 21 | 22 | 15.79% |
| 31 Dec, 20 | 19 | 26.67% |
| 30 Sep, 20 | 15 | -6.25% |
| 30 Jun, 20 | 16 | - |
| 31 Mar, 20 | 16 | -38.46% |
| 31 Dec, 19 | 26 | 100.00% |
| 30 Sep, 19 | 13 | -40.91% |
| 30 Jun, 19 | 22 | 29.41% |
| 31 Mar, 19 | 17 | 750.00% |
| 31 Dec, 18 | 2 | - |
29 institutional shareholders have increased their position in ENOB stock as of 31 Mar 24 compared to 29 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 8 | 100.00% |
| 31 Dec, 23 | 4 | -33.33% |
| 30 Sep, 23 | 6 | -68.42% |
| 30 Jun, 23 | 19 | 46.15% |
| 31 Mar, 23 | 13 | 8.33% |
| 31 Dec, 22 | 12 | -7.69% |
| 30 Sep, 22 | 13 | 44.44% |
| 30 Jun, 22 | 9 | -30.77% |
| 31 Mar, 22 | 13 | 85.71% |
| 31 Dec, 21 | 7 | -30.00% |
| 30 Sep, 21 | 10 | -44.44% |
| 30 Jun, 21 | 18 | 63.64% |
| 31 Mar, 21 | 11 | -8.33% |
| 31 Dec, 20 | 12 | 9.09% |
| 30 Sep, 20 | 11 | 57.14% |
| 30 Jun, 20 | 7 | -12.50% |
| 31 Mar, 20 | 8 | 700.00% |
| 31 Dec, 19 | 1 | -90.00% |
| 30 Sep, 19 | 10 | 100.00% |
| 30 Jun, 19 | 5 | - |
| 31 Mar, 19 | - | - |
| 31 Dec, 18 | - | - |
8 institutional shareholders have reduced their position in ENOB stock as of 31 Mar 24 compared to 4 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 43 | 22.86% | 7,250,533 | 183.48% | 11.01% | 72.99% | 29 | - | 8 | 100.00% |
| 31 Dec, 23 | 35 | 52.17% | 2,557,673 | 71.86% | 3.88% | 76.05% | 29 | 163.64% | 4 | -33.33% |
| 30 Sep, 23 | 23 | -25.81% | 1,488,192 | -19.54% | 2.26% | 20.91% | 11 | - | 6 | -68.42% |
| 30 Jun, 23 | 31 | -22.50% | 1,849,529 | -44.03% | 3.29% | 9.43% | 11 | -47.62% | 19 | 46.15% |
| 31 Mar, 23 | 40 | -6.98% | 3,304,548 | -9.02% | 5.90% | 13.79% | 21 | 16.67% | 13 | 8.33% |
| 31 Dec, 22 | 43 | 10.26% | 3,632,181 | -4.15% | 6.54% | 13.83% | 18 | -5.26% | 12 | -7.69% |
| 30 Sep, 22 | 39 | -23.53% | 3,789,405 | -4.25% | 6.88% | 12.12% | 19 | -51.28% | 13 | 44.44% |
| 30 Jun, 22 | 51 | 18.60% | 3,957,462 | 51.93% | 7.53% | 30.77% | 39 | 62.50% | 9 | -30.77% |
| 31 Mar, 22 | 43 | -2.27% | 2,604,864 | 5.41% | 4.95% | 22.18% | 24 | -20.00% | 13 | 85.71% |
| 31 Dec, 21 | 44 | 37.50% | 2,471,225 | 62.67% | 4.72% | 55.81% | 30 | 76.47% | 7 | -30.00% |
| 30 Sep, 21 | 32 | - | 1,519,126 | -43.08% | 2.91% | 9.08% | 17 | 54.55% | 10 | -44.44% |
| 30 Jun, 21 | 32 | -21.95% | 2,669,110 | -1.63% | 5.66% | 16.82% | 11 | -50.00% | 18 | 63.64% |
| 31 Mar, 21 | 41 | 2.50% | 2,713,431 | 10.91% | 5.80% | 21.09% | 22 | 15.79% | 11 | -8.33% |
| 31 Dec, 20 | 40 | 5.26% | 2,446,617 | 2.71% | 5.24% | 20.07% | 19 | 26.67% | 12 | 9.09% |
| 30 Sep, 20 | 38 | 15.15% | 2,381,996 | -3.57% | 5.11% | 17.98% | 15 | -6.25% | 11 | 57.14% |
| 30 Jun, 20 | 33 | 3.13% | 2,470,086 | 8.00% | 5.33% | 21.82% | 16 | - | 7 | -12.50% |
| 31 Mar, 20 | 32 | -3.03% | 2,287,203 | 6.51% | 4.94% | 22.95% | 16 | -38.46% | 8 | 700.00% |
| 31 Dec, 19 | 33 | 13.79% | 2,147,409 | 83.73% | 4.64% | 72.63% | 26 | 100.00% | 1 | -90.00% |
| 30 Sep, 19 | 29 | - | 1,168,797 | -1.79% | 2.53% | 25.17% | 13 | -40.91% | 10 | 100.00% |
| 30 Jun, 19 | 29 | 61.11% | 1,190,079 | 32.79% | 3.17% | 54.22% | 22 | 29.41% | 5 | - |
| 31 Mar, 19 | 18 | 800.00% | 896,241 | 30374.02% | 2.42% | 3671113.58% | 17 | 750.00% | - | - |
| 31 Dec, 18 | 2 | - | 2,941 | - | 0.01% | - | 2 | - | - | - |
Renovaro Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Renovaro Biosciences's stock was made by Abildgaard Ole on Oct 06 2023, selling - shares at - per share (valued at -).
Renovaro Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | 1 | - | - |
| Q2 2023 | 3 | - | - |
| Q1 2023 | 3 | 1 | 300.00% |
| Q4 2022 | 7 | - | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 5 | 4 | 125.00% |
| Q1 2022 | - | 3 | - |
| Q4 2021 | 9 | 4 | 225.00% |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 1 | 1 | 100.00% |
| Q1 2021 | 3 | - | - |
| Q4 2020 | 5 | - | - |
| Q2 2020 | 3 | 2 | 150.00% |
| Q1 2020 | 1 | 1 | 100.00% |
| Q4 2019 | - | 1 | - |
| Q3 2019 | 9 | 1 | 900.00% |
| Q2 2019 | 10 | 1 | 1000.00% |
| Q1 2019 | 1 | 6 | 16.67% |
| Q4 2018 | 6 | 1 | 600.00% |
| Q3 2018 | 4 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Renovaro Biosciences's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 1 | 1 | 100.00% |
| Q1 2022 | - | 3 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 8 | - | - |
| Q1 2019 | 1 | - | - |
| Q4 2018 | 1 | - | - |
| Q3 2018 | - | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Renovaro Biosciences's stocks.
Renovaro Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| CSBR | Champions Oncology, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| PHVS | Pharvaris N.V. |
| RZLT | Rezolute, Inc. |
| PEPG | PepGen Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| ELYM | Eliem Therapeutics, Inc. |
ENOB Ownership FAQ
Who Owns Renovaro Biosciences?
Renovaro Biosciences is owned by institutional shareholders (11.01%), insiders (0%), and public (0%). The largest institutional shareholder of Renovaro Biosciences is JEFFERIES FINANCIAL GROUP INC. (0% of total shares) and the top mutual fund owner is BlackRock Advantage SMID Cap Fund, Inc. (0.06% of total shares).
Who are the major institutional shareholders of Renovaro Biosciences?
Renovaro Biosciences's major institutional shareholders are JEFFERIES FINANCIAL GROUP INC., OMERS ADMINISTRATION CORP, LAZARD ASSET MANAGEMENT LLC, BALYASNY ASSET MANAGEMENT L.P., and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Renovaro Biosciences shareholders are there?
As of Mar 2024, there are 43 institutional shareholders of Renovaro Biosciences.
What percentage of Renovaro Biosciences is owned by JEFFERIES FINANCIAL GROUP INC?
JEFFERIES FINANCIAL GROUP INC owns 0 shares of Renovaro Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Renovaro Biosciences is owned by OMERS ADMINISTRATION CORP?
As of Jun 2024, OMERS ADMINISTRATION CORP holds 0 shares of Renovaro Biosciences (ENOB), compromising 0% of the company, valued at $0.
What percentage of Renovaro Biosciences is owned by LAZARD ASSET MANAGEMENT LLC?
LAZARD ASSET MANAGEMENT LLC is the third largest holder of Renovaro Biosciences. The company owns 0 of the company's shares outstanding (worth $0).